DOW · sample dossier
Dow Inc.
47/100
FreshGenerated Oct 17, 2026 · 10:00 AM UTC · 2 hours ago
This copy is frozen (Oct 17). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierDOW
EquityDow Inc.XNYS
Decision context
AVOID
74% convictionScore 47 · Avoid
Downsides look heavier than upsides — we wouldn’t start a new position.
The stock trades 21.0% above our estimate.
Current price
$29.93
Estimated value range
$21.37 – $25.58
Gap vs AlphaDog estimate
-21.0%
Narrow evidence — range rests on a single usable method.
Trading above the estimated range reinforces the cautious recommendation.
Market context
Price
Price when available
Pick how far back the chart looks
1 month
+1.5%
3 months
-1.4%
6 months
-15.9%
1 year
+34.8%
Financial trajectory
Executive summary & thesis
Dow Inc. is a materials science manufacturer with a market capitalization of $21.62B, trading at an EV/EBITDA of 9.67 and a Price/Book of 1.36.
- Q2 2026 YoY revenue expanded by 19.7%, representing the single strongest signal of operational top-line recovery.
- TTM free cash flow reached $2.21 per share, providing positive operational cash generation despite negative margins.
- Dow generated a 34.8% 1-year price return and trades above its 50-day moving average as of October 2026.
- Altman Z-score of 1.57 places Dow in the distress zone, compounded by a low Piotroski F-score of 3/9.
- TTM net margin is negative at -3.1%, creating an unhedged valuation multiple with P/E at -16.27.
- Shares dropped 15.9% over 6 months through October 2026 and trade below the 200-day moving average.
Things to keep in mind
- 1Base target implies 21.0% downsideView source
- 2P/E -16.3xView source
- 3Debt/Equity 1.12View source
What to watch next
What changed recently
No material changes found in the last 30 days.
Why this rating
Score 47 · Avoid
Data through
FreshJun 30, 2026
Factor profile
Balanced operator
| Factor | Score |
|---|---|
| Quality | 26 out of 100 (Weak). Business health — profits, returns, and consistency. Higher means a more durable company. |
| Growth | 59 out of 100 (Neutral). How fast sales and earnings are rising. Higher means the business is expanding faster. |
| Value | 62 out of 100 (Neutral). How cheap the stock looks for what you get. Higher means a more attractive price. |
| Safety | 45 out of 100 (Neutral). Balance-sheet cushion and fewer red flags. Higher means less risk of a nasty surprise. |
| Momentum | 46 out of 100 (Neutral). Recent share-price trend. Higher means buyers have been in control lately. |
Another way to look at it
What the optimistic case might still be missing about Dow Inc.
The consensus fixates on a binary turnaround debate around Q2 2026 revenue growth of 19.7% while ignoring that Dow's premium valuation at 9.7 EV/EBITDA—well above peers CBT at 6.8 and EMN at 8.6—leaves zero cushion for an unprofitable business with a -3.1% TTM net margin.
While the Bear camp successfully secured an 'Avoid' verdict on an Altman Z-score of 1.57 and Debt/Equity of 1.12, both sides fall into herd mentality by treating a single quarter of positive EPS ($0.99) as evidence of an imminent structural exit from the downcycle. Extrapolating top-line recovery overlooks a compressed gross margin of 9.8% and subdued ROA of 1.3%, which offer negligible operating leverage against ongoing 2026 Middle East shipping bottlenecks and feedstock volatility. Furthermore, the consensus relies heavily on financial disclosures from the July 23, 2026 report that are 86 days old without pricing in the intermediate -15.9% 6-month share price decline below the 200-day moving average. Market participants should fade the premise that Dow's positive TTM free cash flow of $2.21 per share mitigates severe balance sheet distress underscored by a Piotroski F-score of 3/9.
The consensus treats Dow's EV/EBITDA multiple of 9.7 as acceptable despite representing an unearned valuation premium over profitable peers CBT (6.8) and EMN (8.6) while TTM net margin sits at -3.1%.
Both debate sides overlook that gross margin is compressed at 9.8% and ROA is 1.3%, leaving bottom-line recovery hypersensitive to 2026 Middle East logistics bottlenecks regardless of top-line revenue expansion.
The analysis ignores refinancing and liquidity risks under a Debt/Equity ratio of 1.12 combined with an Altman Z-score of 1.57 in the distress zone and a weak Piotroski F-score of 3/9.
Extrapolating Q2 2026 YoY revenue growth of 19.7% and EPS of $0.99 into a durable operational inflection without evidence of sustained net margin expansion above -3.1%.
Assuming TTM free cash flow of $2.21 per share (or $0.33 per share in the bull case) provides sufficient balance sheet insulation against an Altman Z-score of 1.57.
Overweighting the 34.8% 1-year price gain and short-term trading above the 50-day moving average while ignoring the -15.9% 6-month drawdown and break below the 200-day moving average.
TTM net margin improves from -3.1% to above 0.0%.
Altman Z-score rises above 1.57 out of the financial distress zone.
Cash after investing
See whether Dow Inc. still makes cash after it spends to grow.
- TTM net margin improves from -3.1% to above 0.0%.
- Altman Z-score rises above 1.57 out of the financial distress zone.
- Gross margin expands above 9.8% alongside ROA exceeding 1.3%.
Monitor these triggers
3 checkpoints before the next earnings print
Revenue Growth YoY (baseline: 19.7%) to monitor whether top-line expansion can reverse the negative net margin of -3.1%.
TTM net margin deteriorates below -3.1%.
Debt/Equity ratio increases beyond 1.12.
Revenue growth drops below 19.7% YoY while ROA falls below 1.3%.
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
Run the next one yourself.
You just read a full DOW dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.